{"id":419,"date":"2014-02-24T20:45:58","date_gmt":"2014-02-24T20:45:58","guid":{"rendered":"http:\/\/eurekainfomed.it\/?p=419"},"modified":"2026-08-03T14:12:56","modified_gmt":"2026-08-03T14:12:56","slug":"new-provisions-for-spontaneous-reporting","status":"publish","type":"post","link":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/","title":{"rendered":"New provisions for spontaneous reporting"},"content":{"rendered":"

The Italian regulatory authority AIFA<\/b> has updated, in an information notice<\/a>, \u201cthe procedures for managing Italian reports of suspected adverse reactions to medicinal products forreporter or the reporter’s affiliated organization is not known.\u201d<\/b><\/p>\n

<\/p>\n

New types of spontaneous reports<\/h4>\n

According to the new pharmacovigilance legislation, Marketing Authorization Holders (MAHs) are required to monitor not only the scientific literature for potential reports of suspected adverse reactions, but also communication channels used and populated by patients, such as websites, blogs, vlogs, social networks, internet forums, chats, and health portals<\/b>.<\/p>\n

Any adverse reaction identified through these activities, as explained in the AIFA notice, must be considered a spontaneous report, and the MAH is required to manage from a regulatory perspective those reports considered valid according to EudraVigilance criteria.<\/p>\n

In the same way, reports received from healthcare professionals or patients through any channel, including telephone calls or market research activities, for which it is not possible to determine the identity of the reporter, must also be considered spontaneous reports.<\/p>\n

How to obtain the necessary information about the reporter<\/h4>\n

In all cases where it is not possible to identify either the healthcare institution to which the reporter belongs or the pharmacovigilance responsible person of that institution, as stated in the AIFA communication, \u201cMarketing Authorization Holders must enter the data directly into EudraVigilance within 15 days from the date of receipt of the information for serious adverse reactions, and within 90 days for non-serious adverse reactions.\u201d<\/b><\/p>\n

If, on the other hand, it is possible to identify the healthcare institution to which the reporter belongs, and until the EMA is able to ensure the full functionality of the EudraVigilance database (Article 24 of Regulation (EC) No 726\/2004, as amended by Regulation (EC) 1235\/2010<\/a> of the European Parliament and of the Council), MAHs are required to forward to the pharmacovigilance responsible thcare institution all reports of suspected serious and non-serious adverse reactions occurring within the national territory.<\/p>\n","protected":false},"excerpt":{"rendered":"

The Italian regulatory authority AIFA has updated, in an information notice, \u201cthe procedures for managing Italian reports of suspected adverse reactions to medicinal products forreporter or the reporter’s affiliated organization…<\/p>\n","protected":false},"author":1,"featured_media":420,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25,4],"tags":[],"class_list":["post-419","post","type-post","status-publish","format-standard","has-post-thumbnail","category-pharmacovigilance","category-news"],"yoast_head":"\nNew provisions for spontaneous reporting<\/title>\n<meta name=\"description\" content=\"AIFA, the Italian regulatory authority, has updated, through an information notice, the procedures for managing spontaneous reports of suspected adverse reactions when the identity of the reporter is unknown.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New provisions for spontaneous reporting\" \/>\n<meta property=\"og:description\" content=\"AIFA, the Italian regulatory authority, has updated, through an information notice, the procedures for managing spontaneous reports of suspected adverse reactions when the identity of the reporter is unknown.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/\" \/>\n<meta property=\"og:site_name\" content=\"Eureka Info Med\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-24T20:45:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-03T14:12:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2014\/02\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/ca409c130f9741e5a586ec422bb0a39a\"},\"headline\":\"New provisions for spontaneous reporting\",\"datePublished\":\"2014-02-24T20:45:58+00:00\",\"dateModified\":\"2026-08-03T14:12:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/\"},\"wordCount\":319,\"image\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg\",\"articleSection\":[\"Pharmacovigilance\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/\",\"name\":\"New provisions for spontaneous reporting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg\",\"datePublished\":\"2014-02-24T20:45:58+00:00\",\"dateModified\":\"2026-08-03T14:12:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/ca409c130f9741e5a586ec422bb0a39a\"},\"description\":\"AIFA, the Italian regulatory authority, has updated, through an information notice, the procedures for managing spontaneous reports of suspected adverse reactions when the identity of the reporter is unknown.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg\",\"contentUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2014\\\/02\\\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg\",\"width\":1200,\"height\":900,\"caption\":\"reazioni avverse\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/new-provisions-for-spontaneous-reporting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New provisions for spontaneous reporting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/\",\"name\":\"Eureka Info Med\",\"description\":\"documentazione medico-scientifica e farmacovigilanza\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/ca409c130f9741e5a586ec422bb0a39a\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/009e20f21b91cfd0cd6677ff27909f5f0d8115fedc68149e2f06dbadfdbe12f8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/009e20f21b91cfd0cd6677ff27909f5f0d8115fedc68149e2f06dbadfdbe12f8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/009e20f21b91cfd0cd6677ff27909f5f0d8115fedc68149e2f06dbadfdbe12f8?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/author\\\/claudiospada\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New provisions for spontaneous reporting","description":"AIFA, the Italian regulatory authority, has updated, through an information notice, the procedures for managing spontaneous reports of suspected adverse reactions when the identity of the reporter is unknown.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/","og_locale":"en_US","og_type":"article","og_title":"New provisions for spontaneous reporting","og_description":"AIFA, the Italian regulatory authority, has updated, through an information notice, the procedures for managing spontaneous reports of suspected adverse reactions when the identity of the reporter is unknown.","og_url":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/","og_site_name":"Eureka Info Med","article_published_time":"2014-02-24T20:45:58+00:00","article_modified_time":"2026-08-03T14:12:56+00:00","og_image":[{"width":1200,"height":900,"url":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2014\/02\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/#article","isPartOf":{"@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/"},"author":{"name":"admin","@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/ca409c130f9741e5a586ec422bb0a39a"},"headline":"New provisions for spontaneous reporting","datePublished":"2014-02-24T20:45:58+00:00","dateModified":"2026-08-03T14:12:56+00:00","mainEntityOfPage":{"@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/"},"wordCount":319,"image":{"@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/#primaryimage"},"thumbnailUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2014\/02\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg","articleSection":["Pharmacovigilance","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/","url":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/","name":"New provisions for spontaneous reporting","isPartOf":{"@id":"https:\/\/eurekainfomed.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/#primaryimage"},"image":{"@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/#primaryimage"},"thumbnailUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2014\/02\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg","datePublished":"2014-02-24T20:45:58+00:00","dateModified":"2026-08-03T14:12:56+00:00","author":{"@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/ca409c130f9741e5a586ec422bb0a39a"},"description":"AIFA, the Italian regulatory authority, has updated, through an information notice, the procedures for managing spontaneous reports of suspected adverse reactions when the identity of the reporter is unknown.","breadcrumb":{"@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/#primaryimage","url":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2014\/02\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg","contentUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2014\/02\/reazioni-avverse-segnalazioni-spontanee-disposizioni-aifa.jpg","width":1200,"height":900,"caption":"reazioni avverse"},{"@type":"BreadcrumbList","@id":"https:\/\/eurekainfomed.it\/en\/new-provisions-for-spontaneous-reporting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eurekainfomed.it\/en\/"},{"@type":"ListItem","position":2,"name":"New provisions for spontaneous reporting"}]},{"@type":"WebSite","@id":"https:\/\/eurekainfomed.it\/en\/#website","url":"https:\/\/eurekainfomed.it\/en\/","name":"Eureka Info Med","description":"documentazione medico-scientifica e farmacovigilanza","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eurekainfomed.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/ca409c130f9741e5a586ec422bb0a39a","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/009e20f21b91cfd0cd6677ff27909f5f0d8115fedc68149e2f06dbadfdbe12f8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/009e20f21b91cfd0cd6677ff27909f5f0d8115fedc68149e2f06dbadfdbe12f8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/009e20f21b91cfd0cd6677ff27909f5f0d8115fedc68149e2f06dbadfdbe12f8?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/eurekainfomed.it\/en\/author\/claudiospada\/"}]}},"_links":{"self":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/comments?post=419"}],"version-history":[{"count":3,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/419\/revisions"}],"predecessor-version":[{"id":43555,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/419\/revisions\/43555"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/media\/420"}],"wp:attachment":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/media?parent=419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/categories?post=419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/tags?post=419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}